• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    LightPath Technologies Reports Fiscal 2026 Third Quarter Financial Results

    5/7/26 4:05:00 PM ET
    $LPTH
    Semiconductors
    Technology
    Get the next $LPTH alert in real time by email

    ORLANDO, Fla., May 7, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2026.

    logo (PRNewsfoto/LightPath Technologies)

    Financial Summary:





    Three Months Ended March 31,



    $ in millions



    2026





    2025





    % Change



    Revenue



    $

    19.1





    $

    9.2







    109

    %

    Gross Profit



    $

    7.0





    $

    2.7







    161

    %

    Operating Expenses*



    $

    11.2





    $

    6.1







    83

    %

    Net Loss



    $

    (4.1)





    $

    (3.6)







    15

    %

    Adjusted EBITDA** (non-GAAP)



    $

    1.1





    $

    (1.6)







    170

    %

    *Inclusive of $3.4 million and $0.1 million, respectively, for change in fair value of acquisition earnout liabilities.

    **Reconciliation of this non-GAAP financial measure is provided below.

    Third Quarter Fiscal 2026 & Subsequent Highlights: 

    • Ended the third quarter of fiscal 2026 with a record order backlog of approximately $110.6 million, an increase of 196% from $37.4 million as of June 30, 2025, reflecting growing customer demand for infrared cameras, assemblies, and BlackDiamond™ based optical solutions.
    • Acquired the assets of Amorphous Materials, Inc. ("AM") in January 2026, an industrial manufacturer with complementary Chalcogenide glass melting technologies for large diameter optics, adding a second U.S. manufacturing location for BlackDiamond™ glass.
    • Hosted an Investor Day in February 2026, during which management outlined the Company's updated three pillar growth strategy targeting in excess of $300 million in annual revenue within five years, anchored by assemblies, infrared camera systems, and large defense programs.
    • Appointed Doug Schoen as Senior Vice President of Global Sales and Ryan Workman as Vice President, Business Development & Product Management in April 2026, adding more than 40 combined years of defense, aerospace, and Electro-Optical/Infrared business development experience to accelerate conversion of pipeline into contracted revenue.

    Management Commentary 

    Sam Rubin, President and Chief Executive Officer of LightPath, said: "The third quarter of fiscal 2026 demonstrated continued execution against our vertically integrated strategy, with revenue growing 109% year over year to $19.1 million and gross profit expanding 161% year over year to $7.0 million. We delivered our third consecutive quarter of positive adjusted EBITDA and ended the quarter with a record order backlog of $110.6 million, up 196% from the start of the fiscal year. The scale and quality of our backlog is the clearest indication yet that LightPath has established itself as a mission critical supplier for some of the most important optical and infrared imaging programs in the U.S. and allied defense industrial base.

    "The strategic thesis we have been executing against for the past several years continues to be reinforced by customer behavior and U.S. government policy. The Fiscal Year 2026 National Defense Authorization Act directs the U.S. Department of War to eliminate reliance on optical glass and optical systems sourced from certain foreign nations by January 1, 2030. Our broad offering of BlackDiamond™ chalcogenide glasses, including those licensed exclusively from the U.S. Naval Research Laboratory, along with our infrared cameras, assemblies, and thermal imaging systems, are already designed, manufactured, and delivered in alignment with those requirements. With the addition of AM, we now operate two U.S. based BlackDiamond™ glass production sites and have expanded our infrared glass portfolio to roughly 20 proprietary compositions, which is among the broadest selection of infrared materials available anywhere.

    "Our February Investor Day laid out where we go from here. We are organizing the business around three pillars of growth: optical assemblies, infrared camera systems, and large defense programs of record. Each pillar has an addressable market measured in hundreds of millions to billions of dollars, and each is enabled by the same underlying BlackDiamond™, molding, coating, and camera technologies. Programs such as NGSRI, SPEIR, Apache, border surveillance, and counter UAS are no longer theoretical; they are in production or nearing it, and they increasingly carry BlackDiamond™ content. We are on track to complete the redesign of G5's cooled infrared camera family onto BlackDiamond™ by the end of summer 2026, and beleive that this will position LightPath to meet long range camera demand at scale while competitors continue to work through the Germanium supply constraint.

    "With a strong balance sheet, two operating glass manufacturing facilities, an expanded camera portfolio, and a deeper senior commercial leadership team following the appointments of Doug Schoen and Ryan Workman, we believe LightPath is well positioned to continue converting our record backlog into revenue, expand margins as volume scales, and pursue further accretive M&A that accelerates our transition into a platform provider of mission critical optical and imaging solutions," concluded Rubin.

    Third Quarter Fiscal 2026 Financial Results

    Revenue for the third quarter of fiscal 2026 increased 109% to $19.1 million, as compared to $9.2 million in the same quarter of the prior fiscal year. Revenue was split amongst the Company's product groups in the third quarter of fiscal 2026 and the same quarter of the prior fiscal year as follows:

    Product Group Revenue ($ in millions)***



    Third Quarter of

    Fiscal 2026





    Third Quarter of

    Fiscal 2025





    % Change



    Infrared ("IR") Components



    $

    6.1





    $

    3.6







    69 %



    Visible Components



    $

    4.0





    $

    2.8







    40 %



    Assemblies & Modules



    $

    8.4





    $

    1.9







    355 %



    Engineering Services



    $

    0.6





    $

    0.8







    (29) %



    *** Numbers may not foot due to rounding

    Gross profit increased 161.1% to $7.0 million, or 36% of total revenues, in the third quarter of fiscal 2026, as compared to $2.7 million, or 29% of total revenues, in the same year-ago quarter. The increase in gross margin as a percentage of revenue was primarily driven by the increase in revenue from assemblies and modules, which generally carry higher margins, as well as an improved infrared component mix and manufacturing yields.

    Operating expenses for the third quarter of fiscal 2026 include a fair value adjustment of $3.4 million related to the G5 earnout liability, which will continue to be adjusted through operating expenses until it is fully paid out. Excluding this amount, operating expenses increased $1.8 million, or 30%, to $7.8 million for the third quarter of fiscal 2026, as compared to $6.0 million in the same year-ago quarter. The increase was primarily driven by integration of G5 Infrared and AM, increased sales and marketing spend, higher information technology spend to meet customer security requirements, and increased SG&A personnel costs.

    Net loss in the third quarter of fiscal 2026 totaled $4.1 million, or $0.07 per basic and diluted share, as compared to $3.6 million, or $0.44 per basic and diluted share, in the same year-ago quarter. The year-over-year change in net loss was primarily attributable to the change in fair value of acquisition liabilities for the earnout related to the acquisition of G5 Infrared.

    Adjusted EBITDA** for the third quarter of fiscal 2026 was $1.1 million, as compared to an adjusted EBITDA loss of $1.6 million for the same year-ago quarter. The increase was primarily attributable to the increase in gross profit, driven by higher sales, partially offset by increased SG&A and new product development costs.

    Cash and cash equivalents as of March 31, 2026 totaled $55.2 million, as compared to $4.9 million as of June 30, 2025. Total backlog as of March 31, 2026 was approximately $110.6 million, an increase of 196% compared to $37.4 million as of June 30, 2025.

    Third Quarter Fiscal 2026 Earnings Call

    Management will host an investor conference call at 5:00 p.m. Eastern time today, Thursday, May 7, 2026, to discuss the Company's third quarter fiscal 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

    Q3 FY2026 Earnings Conference Call

    Date: Thursday, May 7, 2026

    Time: 5:00 p.m. Eastern time

    U.S. Dial-in: 1-833-316-1983

    International Dial-in: 1-785-838-9310

    Conference ID: LIGHT

    Webcast: LPTH Q3 FY2026 Earnings Conference Call

    Please join at least five minutes before the start of the call to ensure timely participation.

    A playback of the call will be available through Thursday, May 21, 2026. To listen, please call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 11161627. A webcast replay will also be available using the webcast link above.

    About LightPath Technologies

    LightPath Technologies, Inc. (NASDAQ:LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath's family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials – sold under exclusive license from the U.S. Naval Research Laboratory – to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire, Latvia and China. To learn more, please visit www.lightpath.com.

    **Use of Non-GAAP Financial Measures

    To provide investors with additional information regarding financial results, this press release includes references to EBITDA and adjusted EBITDA, which are non-GAAP financial measures. The Company calculates EBITDA by adjusting net income to exclude net interest expense, income tax expense or benefit, depreciation, and amortization. We also calculate adjusted EBITDA, which excludes, as applicable: (1) stock compensation expenses; (2) the loss on extinguishment of debt; (3) the effect of the non-cash income or expense associated with the mark-to-market adjustments, related to the warrants; (4) the effect of non-cash income or expenses associated with the fair value adjustments related to the acquisition earnout liabilities; (5) acquisition costs, including legal fees and due diligence; and (6) the effect of foreign exchange gains or losses.

    A "non-GAAP financial measure" is generally defined as a numerical measure of a company's historical or future performance that excludes or includes amounts, or is subject to adjustments, so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP. The Company's management believes that these non-GAAP financial measures, when considered together with the GAAP financial measures, provide information that is useful to investors in understanding period-over-period operating results separate and apart from items that may, or could, have a disproportionately positive or negative impact on results in any particular period. Management also believes that these non-GAAP financial measures enhance the ability of investors to analyze underlying business operations and understand performance. In addition, management may utilize these non-GAAP financial measures as guides in forecasting, budgeting, and planning. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, or superior to, financial measures presented in accordance with GAAP. A reconciliation of these non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP is presented in the table below.

    LIGHTPATH TECHNOLOGIES, INC.

    Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure







    (unaudited)













    Three Months Ended





    Nine Months Ended







    March 31,





    March 31,







    2026





    2025





    2026





    2025



    Net loss



    $

    (4,106,287)





    $

    (3,582,460)





    $

    (16,404,698)





    $

    (7,817,202)



    Depreciation and amortization





    1,263,005







    1,463,150







    3,717,691







    3,356,752



    Income tax provision





    91,390







    100,031







    203,216







    160,192



    Interest (income) expense





    (271,641)







    486,833







    282,235







    805,246



    EBITDA



    $

    (3,023,533)





    $

    (1,532,446)





    $

    (12,201,556)





    $

    (3,495,012)



    Stock-based compensation





    562,966







    239,134







    1,261,577







    745,155



    Loss on extinguishment of debt





    —







    418,502







    506,280







    418,502



    Change in fair value of warrant liability





    —







    (870,554)







    —







    (870,554)



    Change in fair value of acquisition earnout liabilities





    3,393,000







    130,445







    12,234,529







    130,445



    Acquisition costs





    145,539







    —







    220,175







    —



    Foreign exchange loss (gain)





    59,195







    (7,627)







    115,264







    (11,701)



    Adjusted EBITDA



    $

    1,137,167





    $

    (1,622,546)





    $

    2,136,269





    $

    (3,083,165)



    % of revenue





    6

    %





    -18

    %





    4

    %





    -12

    %

    Forward-Looking Statements

    This press release includes statements that constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "guidance," "plan," "estimate," "will," "would," "project," "maintain," "intend," "expect," "anticipate," "prospect," "strategy," "future," "likely," "may," "should," "believe," "continue," "opportunity," "potential," and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding expectations, beliefs, hopes, intentions or strategies regarding, among other things, the Company's ability to execute on its growth strategy to deliver revenue growth and value to its shareholders; the Company's belief that it has established itself as a mission critical supplier for programs in the U.S. and allied defense industrial base; the Company's expectations regarding customer behavior and U.S. government policy; the Company's expectations regarding its timing of the redesign of G5's infrared products; the Company's ability to grow its backlog, expand margins as volume scales and pursue acquisitions, as well as other statements that are other than historical fact. These forward-looking statements are based on information available at the time the statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the likelihood that the impact of varying demand for the Company products; the U.S. government's initiatives to move away from using optical systems from certain foreign nations; the inability of the Company to sustain profitable sales growth, convert inventory to cash, or reduce its costs to maintain competitive prices for its products; circumstances or developments that may make the Company unable to implement or realize the anticipated benefits, or that may increase the costs, of its current and planned business initiatives; the Company's reliance on a few key customers; the ability of the Company to obtain needed raw materials and components from its suppliers; the impact that international tariffs may have on our business and results of operations; the impact of political and other risks as a result of our sales to internal customers and/or our sourcing of materials from international suppliers; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; geopolitical tensions, the Russian-Ukraine conflict, and the Hamas-Israel war; the effects of steps that the Company could take to reduce operating costs; and those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by the forward-looking statements contained herein. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Except as required under the federal securities laws and the rules and regulations of the SEC, we do not have any intention or obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

    LIGHTPATH TECHNOLOGIES, INC.

    Condensed Consolidated Balance Sheets

    (unaudited)







    March 31,





    June 30,







    2026





    2025



    Assets

















    Current assets:

















    Cash and cash equivalents



    $

    55,235,181





    $

    4,877,036



    Trade accounts receivable, net of allowance of $49,017 and $24,495





    10,797,645







    9,455,310



    Inventories, net





    13,344,705







    12,858,838



    Prepaid expenses and deposits





    3,440,598







    1,142,661



    Other current assets





    185,503







    40,150



    Total current assets





    83,003,632







    28,373,995





















    Property and equipment, net





    15,828,239







    15,864,061



    Operating lease right-of-use assets





    8,406,283







    7,429,378



    Intangible assets, net





    17,589,628







    15,987,923



    Goodwill





    19,315,177







    13,753,921



    Deferred tax assets, net





    22,233







    22,571



    Other assets





    99,987







    73,917



    Total assets



    $

    144,265,179





    $

    81,505,766



    Liabilities and Stockholders' Equity

















    Current liabilities:

















    Accounts payable



    $

    6,030,975





    $

    7,421,430



    Accrued liabilities





    10,813,017







    5,686,396



    Accrued payroll and benefits





    3,125,747







    2,359,152



    Operating lease liabilities, current





    1,177,423







    1,254,062



    Loans payable, current portion





    113,085







    172,567



    Finance lease obligation, current portion





    271,015







    206,518



    Total current liabilities





    21,531,262







    17,100,125



    Deferred tax liabilities, net





    88,099







    152,760



    Accrued liabilities, noncurrent





    —







    823,000



    Finance lease obligation, less current portion





    460,316







    421,363



    Operating lease liabilities, noncurrent





    9,197,980







    8,326,250



    Loans payable, less current portion





    103,661







    4,804,990



    Total liabilities





    31,381,318







    31,628,488





















    Commitments and Contingencies



































    Series G Convertible Preferred Stock; $0.01 par value; 44,000 shares authorized; 17,346

    and 24,956 shares issued and outstanding



    $

    23,794,184





    $

    34,232,510





















    Stockholders' equity:

















    Preferred stock: Series D, $0.01 par value, voting; 500,000 shares authorized; none issued

    and outstanding





    —







    —



    Common stock: Class A, $0.01 par value, voting; 94,500,000 shares authorized; 61,207,012

    and 42,949,307 shares issued and outstanding





    612,070







    429,493



    Additional paid-in capital





    334,313,395







    244,953,346



    Accumulated other comprehensive income





    1,285,667







    978,686



    Accumulated deficit





    (247,121,455)







    (230,716,757)



    Total stockholders' equity





    89,089,677







    15,644,768



    Total liabilities, convertible preferred stock and stockholders' equity



    $

    144,265,179





    $

    81,505,766



    LIGHTPATH TECHNOLOGIES, INC.

    Condensed Consolidated Statements of Comprehensive Income (Loss)

    (unaudited)







    Three Months Ended





    Nine Months Ended







    March 31,





    March 31,







    2026





    2025





    2026





    2025



    Revenue, net



    $

    19,149,814





    $

    9,167,627





    $

    50,559,747





    $

    24,992,837



    Cost of sales





    12,193,531







    6,503,526







    33,100,562







    17,553,476



    Gross profit





    6,956,283







    2,664,101







    17,459,185







    7,439,361



    Operating expenses:

































    Selling, general and administrative





    6,296,286







    4,448,359







    16,539,617







    11,075,005



    New product development





    1,041,794







    757,938







    2,658,051







    1,998,775



    Amortization of intangible assets





    477,245







    779,025







    1,378,295







    1,469,512



    Change in fair value of acquisition earnout liabilities





    3,393,000







    130,445







    12,234,529







    130,445



    Loss on disposal of property and equipment





    —







    2,068







    4,016







    80,505



    Total operating expenses





    11,208,325







    6,117,835







    32,814,508







    14,754,242



    Operating loss





    (4,252,042)







    (3,453,734)







    (15,355,323)







    (7,314,881)



    Other income (expense):

































    Interest income (expense), net





    271,641







    (486,833)







    (282,235)







    (805,246)



    Loss on extinguishment of debt





    —







    (418,502)







    (506,280)







    (418,502)



    Change in fair value of warrant liability





    —







    870,554







    —







    870,554



    Other expense (income), net





    (34,496)







    6,086







    (57,644)







    11,065



    Total other income (expense)





    237,145







    (28,695)







    (846,159)







    (342,129)



    Loss before income taxes





    (4,014,897)







    (3,482,429)







    (16,201,482)







    (7,657,010)



    Income tax provision





    91,390







    100,031







    203,216







    160,192



    Net loss



    $

    (4,106,287)





    $

    (3,582,460)





    $

    (16,404,698)





    $

    (7,817,202)



    Foreign currency translation adjustment





    1,739







    120,572







    306,981







    (58,869)



    Comprehensive loss



    $

    (4,104,548)





    $

    (3,461,888)





    $

    (16,097,717)





    $

    (7,876,071)



    Loss per common share (basic)



    $

    (0.07)





    $

    (0.09)





    $

    (0.33)





    $

    (0.19)



    Number of shares used in per share calculation (basic)





    58,628,741







    41,363,643







    49,572,872







    40,209,657



    Loss per common share (diluted)



    $

    (0.07)





    $

    (0.09)





    $

    (0.33)





    $

    (0.19)



    Number of shares used in per share calculation (diluted)





    58,628,741







    41,363,643







    49,572,872







    40,209,657



    LIGHTPATH TECHNOLOGIES, INC.

    Condensed Consolidated Statements of Changes in Stockholders' Equity

    (unaudited)









    Temporary Equity





























    Accumulated























    Series G Convertible





    Class A





    Additional





    Other













    Total







    Preferred Stock





    Common Stock





    Paid-in





    Comprehensive





    Accumulated





    Stockholders'







    Shares





    Amount





    Shares





    Amount





    Capital





    Income





    Deficit





    Equity



    Balances at June 30, 2025





    24,956





    $

    34,232,510







    42,949,307





    $

    429,493





    $

    244,953,346





    $

    978,686





    $

    (230,716,757)





    $

    15,644,768



    Issuance of common stock for:

































































    Exercise of stock options, RSUs &RSAs, net





    —







    —







    8,583







    86







    (86)







    —







    —







    —



    Issuance of common stock under private equity placement





    —







    —







    1,600,000







    16,000







    7,878,045







    —







    —







    7,894,045



    Issuance of common stock for acquisition of Visimid





    —







    —







    112,323







    1,123







    348,877







    —







    —







    350,000



    Stock-based compensation on stock options, RSUs &RSAs





    —







    —







    —







    —







    349,624







    —







    —







    349,624



    Foreign currency translation adjustment





    —







    —







    —







    —







    —







    92,383







    —







    92,383



    Net loss





    —







    —







    —







    —







    —







    —







    (2,893,002)







    (2,893,002)



    Balances at September 30, 2025





    24,956





    $

    34,232,510







    44,670,213





    $

    446,702





    $

    253,529,806





    $

    1,071,069





    $

    (233,609,759)





    $

    21,437,818



    Issuance of common stock for:

































































    Exercise of stock options, RSUs &RSAs, net





    —







    —







    120,234







    1,203







    (1,203)







    —







    —







    —



    Exercise of warrants





    —







    —







    739,730







    7,397







    (7,397)







    —







    —







    —



    Issuance of common stock under public equity placement





    —







    —







    8,912,500







    89,125







    65,251,709







    —







    —







    65,340,834



    Stock-based compensation on stock options, RSUs & RSAs





    —







    —







    —







    —







    348,986







    —







    —







    348,986



    Foreign currency translation adjustment





    —







    —







    —







    —







    —







    212,859







    —







    212,859



    Net loss





    —







    —







    —







    —







    —







    —







    (9,405,409)







    (9,405,409)



    Balances at December 31, 2025





    24,956





    $

    34,232,510







    54,442,677





    $

    544,427





    $

    319,121,901





    $

    1,283,928





    $

    (243,015,168)





    $

    77,935,088



    Issuance of common stock for:

































































    Employee Stock Purchase Plan





    —







    —







    2,302







    23







    24,839







    —







    —







    24,862



    Exercise of stock options, RSUs & RSAs, net





    —







    —







    112,723







    1,127







    11,376







    —







    —







    12,503



    Exercise of warrants





    —







    —







    2,728,968







    27,290







    (27,290)







    —







    —







    —



    Fees for issuance of common stock under public equity placement





    —







    —







    —







    —







    (98,293)







    —







    —







    (98,293)



    Issuance of common stock for acquisition of Amorphous





    —







    —







    83,518







    835







    1,026,245







    —







    —







    1,027,080



    Issuance of common stock for acquisition of G5





    —







    —







    297,445







    2,974







    3,146,968







    —







    —







    3,149,942



    Conversion of Series G Preferred to Common





    (7,610)







    (10,438,326)







    3,539,379







    35,394







    10,402,932







    —







    —







    10,438,326



    Stock-based compensation on stock options, RSUs & RSAs





    —







    —







    —







    —







    704,717







    —







    —







    704,717



    Foreign currency translation adjustment





    —







    —







    —







    —







    —







    1,739







    —







    1,739



    Net loss





    —







    —







    —







    —







    —







    —







    (4,106,287)







    (4,106,287)



    Balances at March 31, 2026





    17,346





    $

    23,794,184







    61,207,012





    $

    612,070





    $

    334,313,395





    $

    1,285,667





    $

    (247,121,455)





    $

    89,089,677





































































    Balances at June 30, 2024





    —





    $

    —







    39,254,643





    $

    392,546





    $

    245,140,758





    $

    509,936





    $

    (215,843,575)





    $

    30,199,665



    Issuance of common stock for:

































































    Employee Stock Purchase Plan





    —







    —







    8,232







    82







    10,290







    —







    —







    10,372



    Exercise of Stock Options, RSUs & RSAs, net





    —







    —







    70,309







    703







    (703)







    —







    —







    —



    Issuance of common stock for acquisition of Visimid





    —







    —







    279,553







    2,796







    318,562







    —







    —







    321,358



    Stock-based compensation on stock options, RSUs & RSAs





    —







    —







    —







    —







    264,475







    —







    —







    264,475



    Foreign currency translation adjustment





    —







    —







    —







    —







    —







    271,594







    —







    271,594



    Net loss





    —







    —







    —







    —







    —







    —







    (1,622,745)







    (1,622,745)



    Balances at September 30, 2024





    —





    $

    —







    39,612,737





    $

    396,127





    $

    245,733,382





    $

    781,530





    $

    (217,466,320)





    $

    29,444,719



    Issuance of common stock for:

































































    Exercise of Stock Options, RSUs & RSAs, net





    —







    —







    229,097







    2,291







    (2,291)







    —







    —







    —



    Shares issued as compensation





    —







    —







    49,000







    490







    89,180







    —







    —







    89,670



    Stock-based compensation on stock options, RSUs & RSAs





    —







    —







    —







    —







    231,581







    —







    —







    231,581



    Foreign currency translation adjustment





    —







    —







    —







    —







    —







    (451,035)







    —







    (451,035)



    Net loss





    —







    —







    —







    —







    —







    —







    (2,611,997)







    (2,611,997)



    Balances at December 31, 2024





    —





    $

    —







    39,890,834





    $

    398,908





    $

    246,051,852





    $

    330,495





    $

    (220,078,317)





    $

    26,702,938



    Issuance of preferred stock under private equity placement, net of fees





    24,956







    19,648,488







    —







    —







    —







    —







    —







    —



    Issuance of common stock for:

































































    Employee Stock Purchase Plan





    —







    —







    1,137







    11







    4,002







    —







    —







    4,013



    Exercise of Stock Options, RSUs & RSAs, net





    —







    —







    238,641







    2,387







    788







    —







    —







    3,175



    Issuance of common stock for acquisition of Visimid





    —







    —







    102,700







    1,027







    391,561







    —







    —







    392,588



    Issuance of common stock for acquisition of G5





    —







    —







    1,972,501







    19,725







    4,852,343







    —







    —







    4,872,068



    Issuance of common stock under private equity placement, net of fees





    —







    —







    687,750







    6,878







    1,584,014







    —







    —







    1,590,892



    Issuance of warrants under private placement, net of fees





    —







    —







    —







    —







    177,445







    —







    —







    177,445



    Preferred cumulative dividends plus accretion





    —







    14,751,134







    —







    —







    (14,751,134)







    —







    —







    (14,751,134)



    Stock-based compensation on stock options, RSUs & RSAs





    —







    —







    —







    —







    194,303







    —







    —







    194,303



    Foreign currency translation adjustment





    —







    —







    —







    —







    —







    120,572







    —







    120,572



    Net loss





    —







    —







    —







    —







    —







    —







    (3,582,460)







    (3,582,460)



    Balances at March 31, 2025





    24,956





    $

    34,399,622







    42,893,563





    $

    428,936





    $

    238,505,174





    $

    451,067





    $

    (223,660,777)





    $

    15,724,400



    LIGHTPATH TECHNOLOGIES, INC.

    Condensed Consolidated Statements of Cash Flows

    (unaudited)







    Nine Months Ended







    March 31,







    2026





    2025



    Cash flows from operating activities:

















    Net loss



    $

    (16,404,698)





    $

    (7,817,202)



    Adjustments to reconcile net loss to net cash used in operating activities:

















    Depreciation and amortization





    3,717,691







    3,356,752



    Interest from amortization of loan issuance costs





    90,124







    161,905



    Amortization of fair value of loan





    90,321







    —



    Loss on extinguishment of debt





    506,280







    418,502



    Change in fair value of warrant liability





    —







    (870,554)



    Change in fair value of acquisition earnout liabilities





    12,234,529







    130,445



    Earnout payment for acquisition of G5, net of financing portion





    (3,813,587)







    —



    Loss on disposal of property and equipment





    4,016







    80,505



    Stock-based compensation on stock options, RSUs & RSAs, net





    1,261,577







    745,155



    Provision for credit losses





    (26,034)







    (3,014)



    Change in operating lease assets and liabilities





    (181,814)







    (91,582)



    Inventory write-offs to allowance





    215,129







    135,625



    Deferred taxes





    (64,323)







    (2,368)



    Changes in operating assets and liabilities, net of acquisitions:

















    Trade accounts receivable





    (1,200,965)







    (822,043)



    Other current assets





    (145,353)







    73,362



    Inventories





    (247,597)







    (1,206,340)



    Prepaid expenses and deposits





    (2,182,257)







    (360,439)



    Accounts payable and accrued liabilities





    1,030,382







    389,844



    Net cash used in operating activities





    (5,116,579)







    (5,681,447)





















    Cash flows from investing activities:

















    Purchase of property and equipment





    (1,844,395)







    (580,726)



    Proceeds from sale of equipment





    —







    10,648



    Acquisition of Amorphous





    (7,000,111)







    —



    Acquisition of G5





    —







    (20,250,011)



    Net cash used in investing activities





    (8,844,506)







    (20,820,089)





















    Cash flows from financing activities:

















    Proceeds from exercise of stock options





    12,503







    3,175



    Proceeds from sale of common stock from Employee Stock Purchase Plan





    24,862







    14,385



    Proceeds from issuance of common stock under public equity placement, net of fees





    65,242,541







    —



    Proceeds from issuance of common stock under private equity placement, net of fees





    7,894,045







    437,725



    Proceeds from issuance of preferred stock under private equity placement, net of fees





    —







    18,842,138



    Proceeds from issuance of warrants under private equity placement, net of fees





    —







    4,620,561



    Earnout payment for acquisition of G5, net of operating portion





    (3,536,471)







    —



    Deferred payment for acquisition of Visimid





    —







    (125,000)



    Borrowings on loans payable





    —







    6,659,596



    Loan issuance costs





    —







    (597,465)



    Payments on loans payable





    (5,442,930)







    (149,118)



    Repayment of finance lease obligations





    (168,089)







    (133,711)



    Net cash provided by financing activities





    64,026,461







    29,572,286



    Effect of exchange rate on cash and cash equivalents





    292,769







    (72,133)



    Change in cash and cash equivalents





    50,358,145







    2,998,617



    Cash and cash equivalents, beginning of period





    4,877,036







    3,480,268



    Cash and cash equivalents, end of period



    $

    55,235,181





    $

    6,478,885





















    Supplemental disclosure of cash flow information:

















    Interest paid in cash



    $

    390,457





    $

    66,136



    Income taxes paid



    $

    194,527





    $

    118,016



    Supplemental disclosure of non-cash investing & financing activities:

















    Purchase of equipment through finance lease arrangements



    $

    275,471





    $

    93,048



    Operating right-of-use assets acquired in exchange for operating lease liabilities



    $

    1,956,911





    $

    —



    Issuance of common stock for acquisition of Visimid



    $

    350,000





    $

    713,946



    Issuance of common stock for acquisition of G5, including earnouts



    $

    3,149,942





    $

    4,872,068



    Issuance of common stock for acquisition of AML, including earnouts



    $

    1,027,080





    $

    —



    Accrual of earnout consideration for acquisition of G5



    $

    —





    $

    3,536,471



    Accrual of earnout consideration for acquisition of AML



    $

    1,780,000





    $

    —



    Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note



    $

    —





    $

    3,057,110



    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lightpath-technologies-reports-fiscal-2026-third-quarter-financial-results-302764869.html

    SOURCE LightPath Technologies

    Get the next $LPTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LPTH

    DatePrice TargetRatingAnalyst
    1/29/2026$15.00Buy
    Canaccord Genuity
    4/28/2025$5.50Buy
    Craig Hallum
    1/3/2025$3.00 → $5.00Buy
    H.C. Wainwright
    8/9/2021$5.50 → $3.50Buy
    HC Wainwright & Co.
    More analyst ratings

    $LPTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on LightPath with a new price target

    Canaccord Genuity initiated coverage of LightPath with a rating of Buy and set a new price target of $15.00

    1/29/26 7:01:51 AM ET
    $LPTH
    Semiconductors
    Technology

    Craig Hallum initiated coverage on LightPath with a new price target

    Craig Hallum initiated coverage of LightPath with a rating of Buy and set a new price target of $5.50

    4/28/25 8:43:14 AM ET
    $LPTH
    Semiconductors
    Technology

    H.C. Wainwright reiterated coverage on LightPath with a new price target

    H.C. Wainwright reiterated coverage of LightPath with a rating of Buy and set a new price target of $5.00 from $3.00 previously

    1/3/25 8:00:12 AM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    LightPath Technologies Announces $100 Million Registered Direct Primary and Secondary Offering of Class A Common Stock

    ORLANDO, Fla., June 2, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced that the Company and North Run Strategic Opportunities Fund I, LP (the "Selling Stockholder") have entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 7,142,800 shares of the Company's Class A common stock, of which 3,571,400 shares of Class A common stock are being sold by the Company (the "Primary Offering") and 3,571,400 shares of Class A common stock are being sold by the Se

    6/2/26 8:00:00 AM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Technologies Reports Fiscal 2026 Third Quarter Financial Results

    ORLANDO, Fla., May 7, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2026. Financial Summary:Three Months Ended March 31,$ in millions20262025% ChangeRevenue$19.1$9.2109%Gross Profit$7.0$2.7161%Operating Expenses*$11.2$6.183%Net Loss$(4.1)$(3.6)15%Adjusted EBITDA** (non-GAAP)$1.1$(1.6)170%*Inclusive of $3.4 million and $0.1 millio

    5/7/26 4:05:00 PM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Technologies to Host Third Quarter Fiscal 2026 Earnings Call on May 7 at 5:00 p.m. Eastern Time

    ORLANDO, Fla., April 30, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced it will release financial results for the fiscal third quarter ended March 31, 2026 after market close on May 7, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time on Thursday, May 7, 2026 to discuss the Company's third quarter fiscal 2026 financial results, provide a corporate update, and conclude

    4/30/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director North Run Strategic Opportunities Fund I, Lp sold $681,099 worth of shares (55,284 units at $12.32) (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    5/20/26 4:06:54 PM ET
    $LPTH
    Semiconductors
    Technology

    Director North Run Strategic Opportunities Fund I, Lp sold $3,576,837 worth of shares (293,052 units at $12.21) (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    5/14/26 8:00:23 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form 4 filed by Rubin Shmuel

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    3/30/26 9:22:42 AM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Rubin Shmuel bought $2,452 worth of shares (1,000 units at $2.45), increasing direct ownership by 0.44% to 227,722 units (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    2/25/25 4:05:17 PM ET
    $LPTH
    Semiconductors
    Technology

    Director Crider Kimberly Anne bought $2,510 worth of shares (1,000 units at $2.51), increasing direct ownership by 2% to 44,796 units (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    2/21/25 4:07:50 PM ET
    $LPTH
    Semiconductors
    Technology

    Chief Executive Officer Rubin Shmuel bought $2,560 worth of shares (1,000 units at $2.56), increasing direct ownership by 0.44% to 226,722 units (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    2/21/25 4:06:48 PM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    SEC Filings

    View All

    SEC Form 424B5 filed by LightPath Technologies Inc.

    424B5 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Filer)

    6/3/26 5:21:59 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form 424B5 filed by LightPath Technologies Inc.

    424B5 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Filer)

    6/3/26 5:21:41 PM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LIGHTPATH TECHNOLOGIES INC (0000889971) (Filer)

    6/3/26 5:20:51 PM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    Leadership Updates

    Live Leadership Updates

    View All

    LightPath Appoints Two Senior Sales Executives to Drive Defense and Commercial Growth

    Seasoned Defense and Aerospace Executives to Drive Revenue Growth and Expand Market Reach Across LightPath's Defense and Commercial PlatformsORLANDO, Fla., April 8, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced the appointments of Doug Schoen as Senior Vice President of Global Sales and Ryan Workman as Vice President, Business Development & Product Management, effective April 6, 2026. Both executives bring extensive defense industry leadership experience and will play key roles in accelerating the Compan

    4/8/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Technologies Acquires Amorphous Materials, Inc.

    Strategic Purchase to Add Proprietary Large Diameter Glass Melting Technology of Chalcogenide Glass ORLANDO, Fla., Jan. 20, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced it has acquired the assets of Amorphous Materials, Inc., ("AMI") an industrial manufacturer with complementary Chalcogenide glass melting technologies, in particular for large diameter optics, purchased for aggregate consideration of $7.0 million in cash, with the potential for up to $3 million of additional technical milestone-based equ

    1/20/26 4:59:00 PM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Appoints Israel Piergiovanni as Vice President of Manufacturing to Support Near-Term Growth Initiatives

    Former Luminar Manufacturing Executive to Scale Production and SupportOperational Excellence Across LightPath's Global Footprint ORLANDO, Fla., Nov. 10, 2025 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced the appointment of Israel Piergiovanni as Vice President of Manufacturing to support production scale-up in service of meaningful expected near-term growth. A veteran manufacturing executive,

    11/10/25 4:05:00 PM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    Financials

    Live finance-specific insights

    View All

    LightPath Technologies Reports Fiscal 2026 Third Quarter Financial Results

    ORLANDO, Fla., May 7, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced financial results for its fiscal third quarter ended March 31, 2026. Financial Summary:Three Months Ended March 31,$ in millions20262025% ChangeRevenue$19.1$9.2109%Gross Profit$7.0$2.7161%Operating Expenses*$11.2$6.183%Net Loss$(4.1)$(3.6)15%Adjusted EBITDA** (non-GAAP)$1.1$(1.6)170%*Inclusive of $3.4 million and $0.1 millio

    5/7/26 4:05:00 PM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Technologies to Host Third Quarter Fiscal 2026 Earnings Call on May 7 at 5:00 p.m. Eastern Time

    ORLANDO, Fla., April 30, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced it will release financial results for the fiscal third quarter ended March 31, 2026 after market close on May 7, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time on Thursday, May 7, 2026 to discuss the Company's third quarter fiscal 2026 financial results, provide a corporate update, and conclude

    4/30/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology

    LightPath Technologies to Host Second Quarter Fiscal 2026 Earnings Call on February 11 at 5:00 p.m. Eastern Time

    ORLANDO, Fla., Feb. 4, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced it will release financial results for the fiscal second quarter ended December 31, 2025 after market close on February 11, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time on Wednesday, February 11, 2026 to discuss the Company's second quarter fiscal 2026 financial results, provide a corporate upd

    2/4/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology

    $LPTH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    11/13/24 4:28:50 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by LightPath Technologies Inc. (Amendment)

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    2/13/24 2:51:34 PM ET
    $LPTH
    Semiconductors
    Technology